Crypto-Treasury Surge: Biotech, Blockchain & Big Earnings Shake Markets

August 13, 2025

DENVER, Colo., Aug 13, 2025 (247marketnews.com)- This morning’s market opens against a backdrop of aggressive capital allocation shifts, strategic crypto accumulation, and earnings momentum from players across biotech, Web3, media, and aerospace. As corporate treasuries evolve from cash to crypto, a cohort of public companies are reshaping the balance sheet narrative, one Ethereum, Solana, and/or Bitcoin at a time.

LIXTE Biotech (NASDAQ:LIXT) announced a major pivot in treasury management with a bold policy allowing up to 25% of its reserves in cryptocurrency, including Bitcoin. CEO Geordan Pursglove said the move is aimed at enhancing liquidity, hedging against fiat depreciation, and positioning the company at the “forefront of fintech-enabled financial strategy.” LIXTE will use a regulated custodian to secure its assets, a move that echoes MicroStrategy’s early boldness but from a biotech perch.

180 Life Sciences / ETHZilla (NASDAQ:ATNF) unveiled that it now holds 82,186 Ethereum (ETH) valued at approximately $349 million, with an average purchase price of $3,806.71, alongside $238 million in USD equivalents. Executive Chairman McAndrew Rudisill stated the firm is rapidly executing a strategy to create a long-term, yield-generating Ethereum treasury vehicle. The ETH is expected to be staked via Electric Capital’s proprietary on-chain infrastructure.

With only 32 million shares outstanding as of August 5, the ETH-per-share metric is beginning to draw attention. The company’s ongoing updates will include detailed disclosures on staking yields and performance.

Upexi (NASDAQ:UPXI) launched a high-powered Advisory Committee to guide its expansion in crypto, naming Arthur Hayes, the iconic BitMEX co-founder and CIO of Maelstrom, as its first member. Upexi plans to extend its presence in the Solana ecosystem, supported by strategic partnerships and treasury diversification. CEO Allan Marshall sees the Advisory Committee as a driver for unlocking capital and institutional partnerships.

Hayes commented, “Upexi has executed on its vision with precision,” and aims to help it become the “definitive Solana treasury company.”

DeFi Development Corp. (NASDAQ:DFDV) reported Q2 2025 EPS of $0.84 on revenue of $1.97 million, beating estimates by over $1.26 million. The self-dubbed “MicroStrategy of Solana” has grown its SOL treasury to 1.18 million SOL, funded in part by a $20 million equity line of credit. DFDV operates its own validator infrastructure and remains one of the few public companies actively compounding digital asset yields via on-chain infrastructure.

CEO Joseph Onorati and team will host a YouTube video update tomorrow at 8:00 a.m. ET. View here.

X4 Pharmaceuticals (NASDAQ:XFOR) announced it completed an $85 million private placement, upsized from a previously planned $60 million. The raise includes a mix of common stock and pre-funded warrants, supported by institutional players like Bain Capital Life Sciences, NEA, and BVF Partners. The funds will advance the company’s mavorixafor program in chronic neutropenia and support commercialization efforts for WHIM syndrome.

Momentus (NASDAQ:MNTS) announced that it completed a NASA contract focused on space-based robotics and expects to submit a proposal for a follow-on mission. The mission would test foundational robotics tech for orbital servicing and lunar operations. CEO John Rood emphasized the company’s strategic pivot to support commercial and national security sectors via next-gen robotics.

WEBTOON Entertainment (NASDAQ:WBTN) posted Q2 2025 revenue of $348.3 million, an 8.5% YoY increase, with a narrowed net loss of $3.9 million, down from $76.6 million last year. Adjusted EPS came in at $0.07, vs. $0.18 a year ago. Despite a margin compression, WEBTOON surprised to the upside and announced a major collaboration with Disney to adapt IPs from Marvel, Star Wars, and more into vertical-scroll format comics.

CEO Junkoo Kim called WEBTOON the “global destination for comics,” emphasizing app updates and broader reader engagement as drivers of future growth. Q3 revenue is expected to reach $380M–$390M, with Adjusted EBITDA of $2M–$7M.

The digital asset playbook once pioneered by tech firms is now being rewritten by biotech, consumer goods, and even entertainment giants. From ETHZilla’s Ethereum accumulation to LIXTE’s crypto embrace, and from DeFi Dev’s Solana fortress to WEBTOON’s IP mega-partnerships — the market is witnessing a decisive rotation into tokenized treasuries and digital-first strategies.

Please go to https://247marketnews.com/lixte-biotechnology/ for further LIXT information and 247marketnews.com LIXT disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (LIXT, ATNF, UPXI, XFOR, MNTS, WBTN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.